from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2425c/-

LFCtreatmentdescriptionclass of inhibitor

0.181

Amikacinug/mL Amikacintranslation

-1.274

Cap5-10ug/mL Capreomycintranslation

-1.683

Rox10-50 ug/mL Roxithromycintranslation

-0.707

SM2-5 ug/mL Streptomycintranslation

0.782

Tet5-10 ug/mL Tetracyclinetranslation

2.113

Rif0.2-5ug/mL Rifampicintranscription

0.960

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.888

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.821

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.067

CPZ10-50 ug/mL Chlorpromazinerespiration

0.205

Clofazimine10-13 ug/mL Clofaziminerespiration

0.250

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.652

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.421

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.530

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.755

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.121

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.173

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.664

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.470

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.248

KCN5-20 ug/mL Potassium cyaniderespiration

-0.250

NaN30.2-2 mM Sodium aziderespiration

-1.068

Nigericin50 uM Nigericinrespiration

0.275

TRC10-150 ug/mL Triclosanrespiration

-0.016

TRZ10-25 ug/mL Thioridazinerespiration

-1.351

Valinomycin0.5-10 uM Valinomycinrespiration

-1.140

ZnSO42 mM ZnSO4respiration

-0.436

menadione6-10 ug/mL Menadionerespiration

-0.231

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.846

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.184

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.739

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.551

NRP_1Non-replicating persistence stage 1dosRassociated

-0.423

Amp0.2mg/mL AmpicillincellWall

-0.592

Cephalexin20-100 ug/mL CephalexincellWall

-0.405

Cerulenin0.32-5 ug/mL CerulenincellWall

0.861

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.722

EMB10-20 ug/mL EthambutolcellWall

-0.829

Eta12-40 ug/mL EthionamidecellWall

-0.777

INH0.2-0.4 ug/mL IsoniazidcellWall

0.102

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.955

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.782

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.025

BZA0.12 mg/mL BenzamidearomaticAmides

0.559

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.119

H2O24 mM hydrogen peroxideDNAdamaging

0.104

Levo10 ug/mL LevofloxacinDNAdamaging

-0.445

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.119

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.080

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.242

UVUV-irradiationDNAdamaging

0.808

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.004

Antimycin12.5-50 ug/mL Antimycin A?

-0.778

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.419

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.169

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.022

PA8240.2-2 ug/mL PA-824?

0.061

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.375

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.206

Verapamil50 uM Verapamil?

-0.341

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.516

methoxatin10-20 ug/mL Methoxatin?